⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23777971 | 1.00 | — | — | |
| SCHEMBL23777966 | 0.78 | SLC1A3 (0.39) | — | |
| SCHEMBL1146636 | 0.77 | SLC1A3 (0.47) | — | |
| SCHEMBL2617107 | 0.76 | — | — | |
| Leucine SCHEMBL331557 | 0.76 | SLC7A5 (1.00) | — | |
| Leucine SCHEMBL2478164 | 0.76 | SLC7A5 (1.00) | — | |
| Leucine SCHEMBL8568063 | 0.76 | SLC7A5 (1.00) | — | |
| Leucine SCHEMBL25241602 | 0.76 | SLC7A5 (1.00) | — | |
| D-Leucine SCHEMBL42012 | 0.76 | — | — | |
| Leucine SCHEMBL3888 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101657757-A | Methods of forming a stamp, methods of patterning a substrate, and a stamp and a patterning system for same | MICRON TECHNOLOGY INC US | 2010-02-24 | — | — | CN | claimed |
| WO-2008131032-A1 | METHODS OF FORMING A STAMP, METHODS OF PATTERNING A SUBSTRATE, AND A STAMP AND A PATTERNING SYSTEM FOR SAME | MICRON TECHNOLOGY, INC. (US) | 2008-10-30 | — | — | WO | claimed |
| US-20080257187-A1 | Methods of forming a stamp, methods of patterning a substrate, and a stamp and a patterning system for same | MICRON TECHNOLOGY, INC. (US) | 2008-10-23 | — | — | US | claimed |
| EP-1420800-A4 | MODULATION OF INSULIN-REGULATED AMINOPEPTIDASE (IRAP)/ANGIOTENSIN IV (AT 4) RECEPTOR ACTIVITY | FLOREY HOWARD INST (AU) | 2008-01-23 | — | — | EP | claimed |
| EP-1420800-A1 | MODULATION OF INSULIN-REGULATED AMINOPEPTIDASE (IRAP)/ANGIOTENSIN IV (AT 4) RECEPTOR ACTIVITY | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2004-05-26 | — | — | EP | claimed |
| EP-0765117-B1 | BIOLOGICAL CONTROL OF INSECTS | UNIV TROBE (AU) | 2004-02-18 | — | — | EP | claimed |
| US-20030228314-A1 | ERAAP modulators regulate immune responses | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-12-11 | — | — | US | claimed |
| WO-2003099852-A2 | PEPTIDE DERIVATIZATION PROCESS | RESTORAGEN INC. (US) | 2003-12-04 | — | — | WO | claimed |
| WO-2003011304-A1 | MODULATION OF INSULIN-REGULATED AMINOPEPTIDASE (IRAP)/ANGIOTENSIN IV (AT4) RECEPTOR ACTIVITY | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2003-02-13 | — | — | WO | claimed |
| WO-2026099654-A1 | COMPOSITION COMPRISING ORGANIC POLYMER AND FUNCTIONALIZED TERPENES AND METHODS OF WET ETCHING | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-05-15 | — | — | WO | disclosed |
| US-12343335-B2 | Pharmaceutical composition for treating multiple sclerosis on basis of AMPK inhibitory function and zinc homeostasis control function | ZINCURE CORP. (KR) | 2025-07-01 | — | — | US | disclosed |
| US-20240391951-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | GLYTECH INC (JP) | 2024-11-28 | — | — | US | disclosed |
| US-12103947-B2 | Methods for producing peptide thioester and peptide | GLYTECH, INC. (JP) | 2024-10-01 | — | — | US | disclosed |
| CN-118359733-A | Improved human herpesvirus immunotherapy | 昆士兰医学研究所理事会 | 2024-07-19 | — | — | CN | disclosed |
| US-20030228314-A1 | ERAAP modulators regulate immune responses | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-12-11 | — | — | US | disclosed |
| US-20030228314-A1 | ERAAP modulators regulate immune responses | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-12-11 | — | — | US | disclosed |
| WO-2003099852-A2 | PEPTIDE DERIVATIZATION PROCESS | RESTORAGEN INC. (US) | 2003-12-04 | — | — | WO | disclosed |
| EP-0787014-A4 | USE OF FLEA PROTEASES AND PROTEASE INHIBITORS TO PROTECT ANIMALS FROM FLEA INFESTATION | HESKA CORP (US) | 2001-01-10 | — | — | EP | disclosed |
| EP-0787014-A1 | USE OF FLEA PROTEASES AND PROTEASE INHIBITORS TO PROTECT ANIMALS FROM FLEA INFESTATION | Heska Corporation (US) | 1997-08-06 | — | — | EP | disclosed |
| WO-1996011706-A1 | USE OF FLEA PROTEASES AND PROTEASE INHIBITORS TO PROTECT ANIMALS FROM FLEA INFESTATION | HESKA CORPORATION (US) | 1996-04-25 | — | — | WO | disclosed |